Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Post by Pennystalker69on Jun 22, 2018 12:55pm
105 Views
Post# 28213913

This stock is a hidden gem.

This stock is a hidden gem.I’ve been watching ICO and I’m really happy to see that that phase 2 Bertilimumab study is very positive. Also, even better news is the upcoming results on the Oral Amphotericin B which has a huge market potential and is already used as IV drug with gold standard efficacy. From the articles that I’ve been reading it looks like there’s a very high chance that the Oral Amphotericin B will have great pharmacokinetics and will be in high concentration in the blood. The efficacy is already proven because the parenteral amphotericin B is the gold standard molecule against fungal (like Candida, Cryptcoccal and Aspergillus) and some parasites infection (like Leishmania infections).

My advice for the longs is buy and forget about the stock for a couple month. It will go up and down a lot but don’t worry about the volatility... we’ve pretty much built a very strong floor in the 14-16 cents range in the short term. I think the stock is an easy 10 bagger. If the result on oralB are positive it will be an easy 20 bagger.
<< Previous
Bullboard Posts
Next >>